Variability in grading of ductal carcinoma in situ among an international group of pathologists-Reference-Cited by-同舟云学术

Variability in grading of ductal carcinoma in situ among an international group of pathologists

Published:2021-02-23 Issue:3 Volume:7 Page:233-242
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Seijen Maartje¹^ORCID,Jóźwiak Katarzyna¹²,Pinder Sarah E³⁴,Hall Allison⁵,Krishnamurthy Savitri⁶,Thomas Jeremy SJ⁷,Collins Laura C⁸,Bijron Jonathan⁹,Bart Joost¹⁰¹¹,Cohen Danielle¹²,Ng Wen⁴,Bouybayoune Ihssane³,Stobart Hilary¹³,Hudecek Jan¹⁴,Schaapveld Michael¹⁵,Thompson Alastair¹⁶,Lips Esther H¹,Wesseling Jelle¹¹⁰^ORCID,

Affiliation:

1. Division of Molecular Pathology The Netherlands Cancer Institute Amsterdam The Netherlands

2. Institute of Biostatistics and Registry Research Brandenburg Medical School Theodor Fontane Neuruppin Germany

3. Comprehensive Cancer Centre at Guy's Hospital, School of Cancer & Pharmaceutical Sciences Kings College London London UK

4. Department of Cellular Pathology Guy's and St Thomas' NHS Foundation Trust London London UK

5. Department of Pathology Duke University Medical Center Durham NC USA

6. Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX USA

7. Department of Pathology Western General Hospital Edinburgh UK

8. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston MA USA

9. Department of Pathology Martini Hospital Groningen The Netherlands

10. Department of Pathology Isala Hospital Zwolle The Netherlands

11. Department of Pathology University of Groningen, University Medical Center Groningen Groningen The Netherlands

12. Department of Pathology Leiden University Medical Center Leiden The Netherlands

13. Independent Cancer Patients' Voice London UK

14. Department of Research IT The Netherlands Cancer Institute Amsterdam The Netherlands

15. Department of Psychosocial Research and Epidemiology The Netherlands Cancer Institute Amsterdam The Netherlands

16. Dan L Duncan Comprehensive Cancer Center Baylor College of Medicine Houston TX USA

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.201

Reference38 articles.

1. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey

2. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project

3. Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853

4. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

5. Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

2. Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade;British Journal of Cancer;2024-07-09

3. Extracellular Microenvironment Alterations in Ductal Carcinoma In Situ and Invasive Breast Cancer Pathologies by Multiplexed Spatial Proteomics;International Journal of Molecular Sciences;2024-06-19

4. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment;The Lancet;2024-06

5. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials;Cancer Imaging;2024-04-05